OLMA
OLMA
US68062P1066
Olema Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
178.698.000 142.258.000
25.6%
Operating Income -178.698.000 -142.258.000
25.6%
Pretax Income -162.451.000 -129.474.000
25.5%
Net Income Common Stockholders -162.451.000 -129.474.000
25.5%
-- --
--
-- --
--
ende